Futura Medical (FUM) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.940x

Based on the latest financial reports, Futura Medical (FUM) has a cash flow conversion efficiency ratio of -0.940x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-2.64 Million ≈ $-320.73 USD) by net assets (GBX2.81 Million ≈ $341.31 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See defensive interval ratio of Futura Medical to measure how many days the company can operate on defensive assets alone.

Futura Medical - Cash Flow Conversion Efficiency Trend (2001–2025)

This chart illustrates how Futura Medical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Futura Medical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Futura Medical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Unicorn Mineral Resources PLC LSE:UMR	N/A
Phoenix Global Mining Ltd LSE:PXC	-0.011x
Cykel AI PLC LSE:CYK	-2.040x
Norman Broadbent Plc LSE:NBB	0.741x
t42 IoT Tracking Solutions PLC LSE:TRAC	-0.185x
Thruvision Group PLC LSE:THRU	-0.076x
Getech Group LSE:GTC	-0.085x
Adomos SA PA:ALADO	-0.008x

Annual Cash Flow Conversion Efficiency for Futura Medical (2001–2025)

The table below shows the annual cash flow conversion efficiency of Futura Medical from 2001 to 2025. For the full company profile with market capitalisation and key ratios, see Futura Medical (FUM) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	GBX2.81 Million ≈ $341.31	GBX-5.58 Million ≈ $-678.54	-1.988x	-4164.32%
2024-12-31	GBX8.96 Million ≈ $1.09K	GBX438.41K ≈ $53.34	0.049x	-53.02%
2023-12-31	GBX5.48 Million ≈ $666.37	GBX570.25K ≈ $69.38	0.104x	+108.51%
2022-12-31	GBX4.72 Million ≈ $574.23	GBX-5.78 Million ≈ $-702.69	-1.224x	-207.24%
2021-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.87 Million ≈ $-471.26	-0.398x	+92.52%
2020-12-31	GBX853.54K ≈ $103.85	GBX-4.54 Million ≈ $-552.79	-5.323x	+95.71%
2019-12-31	GBX53.65K ≈ $6.53	GBX-6.66 Million ≈ $-809.87	-124.063x	-23226.94%
2018-12-31	GBX8.85 Million ≈ $1.08K	GBX-4.71 Million ≈ $-572.83	-0.532x	-16.00%
2017-12-31	GBX9.11 Million ≈ $1.11K	GBX-4.17 Million ≈ $-507.95	-0.458x	-74.94%
2016-12-31	GBX12.58 Million ≈ $1.53K	GBX-3.30 Million ≈ $-401.27	-0.262x	+76.61%
2015-12-31	GBX4.79 Million ≈ $582.35	GBX-5.36 Million ≈ $-652.63	-1.121x	-255.27%
2014-12-31	GBX9.72 Million ≈ $1.18K	GBX-3.07 Million ≈ $-373.13	-0.315x	+84.53%
2013-12-31	GBX987.77K ≈ $120.18	GBX-2.01 Million ≈ $-245.04	-2.039x	-201.85%
2012-12-31	GBX2.87 Million ≈ $349.59	GBX-1.94 Million ≈ $-236.14	-0.675x	-1.47%
2011-12-31	GBX2.76 Million ≈ $335.57	GBX-1.84 Million ≈ $-223.39	-0.666x	+42.71%
2010-12-31	GBX901.00K ≈ $109.63	GBX-1.05 Million ≈ $-127.39	-1.162x	-63.37%
2009-12-31	GBX1.85 Million ≈ $225.46	GBX-1.32 Million ≈ $-160.36	-0.711x	+68.03%
2008-12-31	GBX886.00K ≈ $107.80	GBX-1.97 Million ≈ $-239.81	-2.225x	-170.33%
2007-12-31	GBX2.77 Million ≈ $337.39	GBX-2.28 Million ≈ $-277.65	-0.823x	-75.43%
2006-12-31	GBX3.95 Million ≈ $480.36	GBX-1.85 Million ≈ $-225.33	-0.469x	+56.29%
2005-12-31	GBX1.98 Million ≈ $240.91	GBX-2.12 Million ≈ $-258.55	-1.073x	-177.22%
2004-12-31	GBX3.75 Million ≈ $456.02	GBX-1.45 Million ≈ $-176.54	-0.387x	+31.27%
2003-12-31	GBX2.41 Million ≈ $293.11	GBX-1.36 Million ≈ $-165.11	-0.563x	+19.43%
2003-01-31	GBX1.52 Million ≈ $184.82	GBX-1.06 Million ≈ $-129.21	-0.699x	-8.85%
2002-01-31	GBX2.00 Million ≈ $243.22	GBX-1.28 Million ≈ $-156.23	-0.642x	-159.76%
2001-01-31	GBX-294.00K ≈ $-35.77	GBX-316.00K ≈ $-38.45	1.075x	--

About Futura Medical

LSE:FUM UK Biotechnology

Market Cap

$38.34K

GBX315.08 Million GBX

Market Cap Rank

#31462 Global

#1236 in UK

Share Price

GBX0.54

Change (1 day)

+0.37%

52-Week Range

GBX0.53 - GBX13.43

All Time High

GBX84.52